PRIMODOG
PRIMODOG
Authorised
- Canine parvovirus, Live
Product identification
Medicine name:
ПРИМОДОГ
PRIMODOG
Active substance:
- Canine parvovirus, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, Live5.50/log10 cell culture infective dose 501.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France SCS
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2092
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 24/07/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 24/07/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 24/07/2024
How useful was this page?:
